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Abstract
 .  .The interaction of rotenone with active ‘pulsed’ and thermally de-activated ‘resting’ membrane-bound Complex I
  . .Kotlyar, A.B. and Vinogradov, A.D. 1990 Biochim. Biophys. Acta 1019, 151–158 as revealed by inhibition of
NADH-ubiquinone- and ubiquinol-NADq reductase activities was studied. K s1P10y9 M, k s5P107 My1 miny1 andi on
y1  . y8 k s0.02 min inhibitory effect of rotenone on NADH oxidation and K s2P10 M inhibition of reverse electronoff i
.transfer were determined for pulsed enzyme. The equilibrium between de-activated and active enzyme is reached
 .K;100 after the slow strongly temperature-dependent de-activation process has completed. Rotenone partially prevents
and reverses the enzyme de-activation. About two order of magnitude difference in affinity of rotenone to the active and
de-activated forms of the enzyme was demonstrated. The strong difference in rotenone sensitivity of the direct and reverse
qreactions can not be accounted for Dm -dependence of rotenone binding. We propose that two rotenone-specific inhibitoryH
sites exist in Complex I: one is involved in NADH oxidation by ubiquinone and the other is operating in ubiquinol-NADq
reductase reaction. The affinities of rotenone for both sites are strongly altered upon the slow enzyme activerinactive
transition.
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1. Introduction
 .NADH-ubiquinone oxidoreductase EC 1.6.99.3 ,
w xoperationally termed Complex I 1–3 is an extraordi-
narily complex proton motive device of the mito-
chondrial respiratory chain. The enzyme comprises of
more than 40 different polypeptides that are encoded
w xboth in the nuclear and mitochondrial genomes 4 .
w x w xFMN 5 , several iron-sulfur clusters 6 and bound
w xubiquinone 1,7 participate in the reversible electron
transfer from NADH to bulk ubiquinone coupled
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with the proton translocation across the mitochondrial
inner membrane. Despite a great progress in the
w xstructural studies of the mammalian 3,4 , Neu-
w xrospora crassa 8 enzymes and their simpler bacte-
w xrial counterparts 9,10 , neither the sequence of elec-
tron transfer between the intrinsic enzyme redox
components nor the mechanism of proton transloca-
tion are known.
The specific inhibitors have proved to be a useful
tool for studies on the mechanism of electron transfer
and proton translocation in the respiratory chain.
w x w xRotenone 11–15 and piericidin 16 are the most
powerful specific inhibitors of Complex I which are
qwidely used for dissection of the Dm -generatingH
electron transfer reactions in NADH-ubiquinone re-
gion of the respiratory chain. It is generally accepted
that rotenone blocks the electron transfer between the
Complex I-associated iron-sulfur clusters and
w xubiquinone pool 15 . More specifically, rotenone
prevents a formation of the Complex I-associated
w xubisemiquinone species 7,17 thus most likely it
inhibits the electron transfer between iron-sulfur cen-
ter N-2 and tightly bound ubiquinone. Ernster et al.
w x12 demonstrated no reactivation of NADH oxidase
by mixing together rotenone- and antimycin-treated
particles as it might be expected for the specific
irreversible inhibition. Restoration of NADH oxidase
in the combination of rotenone-treated and ether-ex-
tracted particles has been claimed in other studies
w x18 . The specificity and stoichiometry of rotenone
binding was the subject of the detailed studies of
w xSinger’s group 14,19–21 . They found that rotenone
and piericidin bind to the specific inhibitory site at
NADH-ubiquinone junction and to some other hy-
drophobic components in the submitochondrial parti-
w xcles 14,19 . BSA readily dissociates rotenone from
the ‘unspecific’ sites leaving the enzyme in the inhib-
ited form which tends to reactivate only after several
w xrepeated washing with albumin 14 . The inhibitory
rotenone was extracted from the particles in its origi-
nal chemically unmodified form by acetone, however
addition of unlabelled rotenone to the particles previ-
w14 xously labelled with C rotenone did not result in
w xdisplacement of the bound label 14 . Photolabelling
w xof Complex I with arylazido-analogue 22 and
w3 x w xH dihydrorotenone 23 showed that 33 kDa mito-
chondrially encoded subunit is involved and evidence
have been presented that binding of rotenone results
in gross conformational changes of the enzyme mov-
w xing several of the subunits away from each other 24 .
The binding and inhibition by rotenone is believed to
w xbe non-competitive with ubiquinone 25–29 . Despite
extensive studies on rotenone inhibition several obvi-
ous questions concerning the enzyme-inhibitor inter-
action either have not been answered or still are
controversial. For example, we were unable to find in
the literature K values for inhibition of anyi
rotenone-sensitive reaction catalyzed by the mem-
brane-bound or isolated preparations of Complex I:
the I values scattered in the literature and expressed50
as mol of the inhibitor per mg of protein are almost
meaningless when reversibility of the inhibition, its
time-dependency and the stoichiometry of the spe-
cific binding are ill-defined.
In addition to the extremal structural complexity of
the rotenone-sensitive enzyme the latter demonstrates
functional heterogeneity. Following the pioneering
w xobservations of Tyler et al. 30 we have provide
w xevidence that the membrane-bound 31,32 and iso-
w x lated 33 Complex I exist in the ‘resting’ de-
.  .activated or ‘pulsed’ active forms. The slow inter-
conversion between those forms depends on several
w xfactors 34 and there are strong reasons to believe
that the NADH-ubiquinone reductase in submito-
.chondrial particles or as purified Complex I as pre-
pared is always a mixture of pulsed and resting
forms. It was rather unexpectedly shown that ther-
mally de-activated Complex I within tightly coupled
submitochondrial particles becomes partially reacti-
 qvated as revealed by the energy-dependent NAD
.reduction after incubation in the presence of rotenone
w xand subsequent removal of the inhibitor 31 . Further
studies on Complex I-rotenone interaction may pro-
vide new information on the functional properties of
NADH-ubiquinone reductase. The studies reported
here were concerned with two mutually related sub-
jects: one was to quantitate the kinetics and thermo-
dynamics of the rotenone-induced inhibition; the sec-
ond part was aimed to further examination of the
slow activerinactive enzyme transition.
2. Materials and methods
 .Coupled submitochondrial particles SMP were
w xprepared as described previously 31 . Protein content
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w xwas determined with biuret reagent 35 . Two types
of the preparations were used.
2.1. De-acti˝ated particles
 .SMP 5 mgrml were suspended in 0.25 M su-
crose, 50 mM TrisrCly, 0.2 mM EDTA, 2 mM
 .malonate potassium salts, pH 8.0 and oligomycin
 .0.5 mgrmg of protein were added. The mixture
was incubated for 1 h at 308C, cooled and stored
 .during the experiments at room temperature ;208C .
De-activated particles showed prominent lag-phase in
their NADH oxidase or succinate-supported NADq
reduction and both activities were strongly inhibited
2q 2q w xby Ca or Mg 32 .
2.2. Acti˝ated particles
 .SMP 5 mgrml suspended and treated with
oligomycin as described before were incubated aero-
bically with a constant stirring in the presence of 1
mM NADPH for 20 min. The suspension was passed
w xthrough the Sephadex column as described 17
 .bovine serum albumin was excluded , cooled and
stored during the experiments at 08C. Occasionally,
when very diluted suspensions were used less than
.50 mgrml the activation was reached by the addi-
tion of 5 mM NADH to the assay cuvettes and
incubation for a time period needed for complete
oxidation of NADH followed spectrophotometri-
.cally . The activated particles showed no lag-phase in
their NADH oxidase or succinate-supported NADq
reduction and both activities were insensitive to Ca2q
2q w xor Mg 32 .
The enzymatic activities were assayed at 258C in
the standard reaction mixture containing 0.25 M su-
y  .crose, 50 mM TrisrCl , 0.2 mM EDTA pH 8.0 .
Other additions and the details of the experiments are
described in the legends to the figures.
 .Rotenone stock solution was dissolved in
dimethylsulfoxide. The solubility of rotenone in dif-
ferent solvents at 208C was determined as follows.
The solid dry rotenone was stirred in dark in water,
 .octane, octanol and cyclohexane spectrally pure for
4 hours. The suspensions were centrifuged and the
U.V. spectra of clear supernatants were recorded. The
concentrations of saturated rotenone solutions were
calculated using EmMs17. The latter value was292
determined using analytically prepared rotenone solu-
tion in ethanol. The solubilities determined were:
water - 1.6 mM; octane - 0.3 mM; octanol - 6.2 mM;
cyclohexane - 1.2 mM. The organic solventrwater
partition coefficients calculated as the solubilities
ratio were: octanerwater: ;200; octanolrwater:
;4000; cyclohexanerwater: ;800. Almost the
same partition coefficients for octanerwater and cy-
clohexanerwater were determined by measuring
rotenone concentrations after shaking and separation
of two-phase systems. The final concentration of
rotenone in all the experiments never exceeded the
solubility limit.
Rotenone, NADH, NADq, malonate, succinate,
oligomycin, gramicidin D, EDTA, antimycin A,
 .bovine serum albumin BSA, fraction V were from
 .  .Sigma USA ; Tris was from Serva FRG . Piericidin
was a kind gift from Dr. A.B. Kotlyar Department of
.Biochemistry, Tel-Aviv University, Israel . Other
chemicals were of the highest quality commercially
available. All calculations and curve fittings were
performed using GIM Version 2 computer program
 .A. Drachev Copyright .
3. Results
3.1. Kinetics of the acti˝e Complex I inhibition by
rotenone
Trivial interpretation of the enzyme-inhibitor inter-
action is possible when the reversible inhibition is
studied under the steady-state conditions where the
concentration of a single enzyme specie is much less
that of the inhibitor and when all the equilibria are
established instantly within the time scale of an as-
say. Those conditions are definitely not hold for
inhibition by rotenone. The possible difficulties in
clear interpretation of the inhibition mechanism may
result from the heterogeneity of the rotenone-sensi-
w xtive Complex I preparations 31–34 . Since the condi-
tions for the reversible interconversion between rest-
ing and pulsed enzyme and some diagnostic tools to
measure a fraction of the active enzyme have been
w xestablished 32,34 , it was of interest to measure the
parameters of functionally homogeneous Complex
I-rotenone interaction. Fig. 1 depicts the inhibition
time-course for the pulsed particles under the condi-
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 .Fig. 1. Panel A Time-course of NADH oxidase inhibition by
 .rotenone. SMP 12 mgrml, approx. 2 nM Complex I were
placed in the standard reaction mixture and the enzyme was
 .activated by the addition of 5 mM NADH see Section 2 .
 .Gramicidin 0.04 mgrml was then added and the reaction was
started by the addition of NADH where indicated. The numbers
 .on the curves indicate the final concentration of rotenone Rot.
 .expressed in nM. Panel B Semilogarithmic anamorphoses of the
rate decrease at different rotenone concentrations. ˝ , zero-ordero
rate of NADH oxidation in the absence of rotenone; ˝ , thet
‘instant’ values of the rates approximated within 10 s time
 .intervals. Panel C The dependence of apparent first-order inhi-
bition rate constant on the concentration of rotenone.
tions where the inhibitor concentration was much
higher than that of the enzyme. The inhibition was
evidently time-dependent and it obeys first-order ki-
netics both as a function of time and the inhibitor
concentration. The second-order rate constant of 5P
107 My1 miny1 was determined from the data shown
in Fig. 1. The inhibition by 1 mM rotenone was
instant within the time resolution limit as it might be
expected from the second-order rate constant value.
When NADH oxidase activity was titrated by
preincubation of the relatively concentrated suspen-
sion of SMP with rotenone the straight line was
 .obtained Fig. 2A . This is in accord with the earlier
¨ w xresults of Lindahl and Oberg 11 and Ernster et al.
w x12 who have interpreted their data in terms of the
irreversible inhibition. The amount of the rotenone-
titrated component calculated by extrapolation of the
straight line was 0.16 nmolrmg of protein. This is in
a reasonable agreement with FMN content in sub-
w xmitochondrial particles 36,37 suggesting 1:1 stoi-
chiometry for the NADH-ubiquinone reductase: in-
hibitory rotenone. Obviously, no clear cut border
between reversible and irreversible inhibition exists
and an appearance of an inhibition as either the linear
 .hyperbolic or titration-type as in Fig. 2A curves
depends on K value and the relative concentrationsi
of an enzyme and inhibitor. Indeed, when the titration
experiment was carried out in the diluted system a
 .simple hyperbolic inhibition was evident Fig. 2B .
 .The hyperbolae shown in Fig. 2B curve 1 fits the
simple single site directed reversible inhibition with
K value of 1 nM. Since Complex I is the proton-i
qtranslocating enzyme and Dm generation isH
rotenone-sensitive it was of a considerable interest to
qfind out whether Dm has any effect on the en-H
zyme-inhibitor interaction. The results presented in
Fig. 2B show that this is not the case. The K valuei
and the second-order rate constant for a formation of
the enzyme-inhibitor complex give the calculated
first-order dissociation rate constant of 0.05 miny1.
The latter was directly estimated in the experiments
shown in Fig. 3. Reasonable coincidence between the
 y1. calculated 0.05 min and experimental 0.02
y1.min values was obtained. The experiment shown
in Fig. 3 provided an independent approach to sup-
port a simple model for a single-site directed re-
versible inhibition. It could be anticipated that the
final level of the NADH oxidase activity reached
after equilibration followed the dilution of the stoi-
chiometric enzyme-rotenone complex would follow
approximately the square root dependence on the
added complex concentration. When the ‘stoichio-
 .metric’ enzyme-rotenone complex 0.5 mM was di-
luted 100- and 1000-fold and left to equilibrate for 2
hours in the medium containing no BSA as shown in
Fig. 3, the final levels of the activity recovered were
30% and 63% of the original uninhibited level,
whereas the theoretical calculations assuming K of 1i
nM give the values of 36 and 72, respectively.
3.2. Kinetics of the de-acti˝ated Complex I interac-
tion with rotenone
Fig. 4 illustrates qualitative difference in the inter-
action of rotenone with active and de-activated Com-
plex I. When the reaction was started by the simulta-
neous addition of NADH and rotenone to the pulsed
enzyme the time dependent progressive inhibition
( )V.G. Gri˝enniko˝a et al.rBiochimica et Biophysica Acta 1319 1997 223–232 227
 .  .  .Fig. 2. Relative affinities of rotenone to the inhibitory site s . Panel A Activated SMP 2.8 mgrml, approx. 0.4 mM Complex I were
incubated in the standard reaction mixture for 20 min at 258C and residual initial rate of NADH oxidation was measured as in Fig. 1.
 .  . 100% correspond to the specific activity of 1.0 mmolrmin per mg of protein. Panel B curve 1 ‘ , SMP 48 mgrml, approx. 8 nM
.Complex I were activated in the assay cuvette as in Fig. 1, and preincubated with rotenone in the presence of gramicidin and 10 mM
 .  .malonate for 20 min at 258C and the residual NADH oxidase activity was then measured; v , the same as ‘ , except that preincubation
 . qwith rotenone was made in the presence of 10 mM succinate no gramicidin and malonate to maintain Dm ; 10 mM malonate andH
gramicidin were added simultaneously with 100 mM NADH to measure the residual activity. Curve 2, the reverse electron transfer
 .activity. The preincubation was as described for curve 1 ‘ except that no gramicidin and malonate were added and the residual rate of
NADq reduction was measured after simultaneous addition of 10 mM succinate and 1 mM NADq. 100% correspond to the specific
activity of 0.2 mmol of NADq reducedrmin per mg of protein. Curve 3, de-activated SMP were preincubated with rotenone as described
 .for curve 1 ‘ and the residual steady-state NADH oxidase 1 min after 5-times dilution of the preincubation medium with the standard
 .assay mixture containing 100 mM NADH and gramicidin was measured. The controls 100% for each point correspond to the activity
measured in the presence of the residual amounts of rotenone added with the preincubation medium to the assay system. The maximal
 .inhibition by that residual rotenone did not exceed 10%. Panel C The same as Panel B, curve 3, except for enzyme concentration was
0.5 mgrml and rotenone concentration range which was increased to show interaction of the inhibitor with de-activated enzyme. The
activity was measured after 200-fold dilution into the assay mixture. All the continuos lines corresponds to the theoretical titration curves
for the reversible single site inhibition with K values of 1 nM, 20 nM and 80 nM for the curves 1, 2 and 3, respectively.i
Fig. 3. Kinetics of NADH oxidase reactivation after dilution of
 .  . the rotenone-inhibited enzyme. Panel A v active SMP 3
.mgrml, approx. 0.5 mM Complex I were preincubated with 0.5
mM rotenone for 20 min at 208C. The suspension was diluted
1000-times with the standard reaction mixture containing BSA 1
.mgrml . 2 ml of the diluted mixture were placed into the assay
cuvette at the time indicated and NADH oxidase was measured
 .  .  .as in Fig. 1. ‘ , ˝ no rotenone was added . Panel B
Semilogarithmic anamorphose of the curve shown in Panel A; the
first-order rate constant determined from the straight line is equal
to 0.02 miny1.
Fig. 4. Time-course of the active and de-activated enzymes
 .  .inhibition by rotenone and piericidin. A SMP 25 mgrml were
activated by the consumption of 5 mM NADH. Gramicidin was
added and reaction was initiated by the simultaneous addition of
 .  .NADH curve 1, control and rotenone 20 nM, curve 2 or
 .  .  .piericidin 4.5 nM, curve 3 . B de-activated SMP 25 mgrml
 .were preincubated for 8 min with no inhibitors curve 1 or in the
 . presence of 20 nM rotenone curve 2 or 4.5 nM piericidin curve
.3 and the reaction was started by the addition of NADH. Note
 .short prominent lag-phase in the control assay curve 1 .
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 .was observed panel A, curve 2 . However, when
completely de-activated enzyme was preincubated
with rotenone for a time period needed to reach about
80% inhibition of the active enzyme and the reaction
was started by NADH, no inhibition was observed
and the time needed to reach 80% inhibition was
 .almost the same panel B, curve 2 . Interestingly, the
same difference in the inhibition pattern was demon-
 .strated for piericidin curves 3 . The results are in
agreement with the earlier data of Burgos and Red-
w xfearn 13 and suggest that either rotenone does not
interact with the de-activated enzyme or the inhibitor
has much lower affinity to the latter. To solve this
alternative the equilibrium titration experiments were
carried out using de-activated enzyme and K valuei
of 80 nM was determined Fig. 2, panel B, curve 3
.and panel C . That value and K for the activei
enzyme were independently verified in the experi-
ments aimed to determine the residual rotenone con-
centration in the medium after incubation with active
 .and de-activated enzyme preparation Fig. 5 . The
experimental points closely correlate with the pre-
dicted values calculated assuming K value for ac-i
tive and de-activated enzyme preparations of 1 nM
and 80 nM, respectively.
3.3. Slow acti˝er inacti˝e transition as an equilib-
rium process
In our previous publications on the activerinactive
Complex I transition the thermally induced de-activa-
tion process was considered as an irreversible pro-
cess, where the only specific pathway for reactivation
wincludes at least a single slow enzyme turnover 31–
x34 . However, it has been noted that partial reactiva-
tion slowly occurred as revealed by its catalytic
activity in the energy-dependent reverse electron
.transfer when thermally de-activated SMP were in-
w xcubated with rotenone 31 . This unexpected finding
have prompted us to get closer insight in the kinetics
of the thermal de-activation. Fig. 6 depicts the time-
course of the NADH oxidase and reverse electron
transfer activities de-activation which appears as the
first-order reactions. However, when the de-activa-
tion was followed for a longer time the residual
rotenone-sensitive activities remain constant indicat-
ing that the process reached an equilibrium. The same
equilibrium level of the residual activity was deter-
Fig. 5. Comparison of binding of rotenone with active and
de-activated SMP. The samples of active and de-activated SMP
 .50 mgrml, approx. 8 nM Complex I were incubated in the
standard mixture for 20 min at 208C with different concentrations
of rotenone indicated on abscissa. The suspensions were cooled
and particles were separated by centrifugation at 48C 1 h, 30000
= g. No NADH oxidase activity was present in the supernatants.
The amount of unbound rotenone in the supernatants was deter-
mined by their inhibitory effect on NADH oxidase activity of
active SMP as follows. 1 ml samples of the supernatants were
mixed with 1 ml of the assay mixture and NADH oxidase
 .activities of active SMP 25 mgrml, approx. 4 nM Complex I
were measured after 20 min preincubation at 258C in the assay
 .mixtures containing the supernatants with unbound rotenone. v
 .Rotenone was preincubated with active SMP; ‘ rotenone was
preincubated with de-activated SMP. The continuos lines were
theoretically calculated assuming K values for rotenone of 1 nMi
and 80 nM for active and de-activated SMP, respectively. The
upward deflections of the experimental points most likely due to
unspecific rotenone binding at the hydrophobic membrane phase
see partition coefficients for rotenone in Section 2 and Refs.
w x.14,19 .
mined at 30, and 398C, whereas the rate of de-activa-
tion was extremely temperature-dependent in accord
w xwith our previous reports 31,33 .
3.4. Effect of rotenone on the acti˝er inacti˝e transi-
tion
It could be anticipated from the dramatic differ-
ence in the inhibitor affinity to the active and de-
activated enzyme and from the equilibrium between
 .those forms Fig. 6 , that rotenone should have pro-
found effect on the equilibration between the active
and de-actived forms of Complex I. In order to
demonstrate and quantitate the activating effect of
rotenone the following experimental approach was
used. In accord with the data reported by Kotlyar and
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w x Gutman 38 but not in agreement with their inter-
.pretation, see Fig. 2 and Section 4 we found that
sensitivity of the energy-dependent electron transfer
to rotenone is considerably less than the NADH-
 .ubiquinone reductase or NADH oxidase Fig. 2 .
Moreover, inhibition of the reverse electron transfer
was rapidly abolished in the presence of sufficient
amounts of BSA. Thus, the active enzyme fraction
could be measured in the reverse electron transfer
assay in the presence of BSA. The results presented
in Fig. 7 show that rotenone partially protects the
enzyme against de-activation and partially reactivates
the enzyme after the de-activation process has com-
 .pleted. It was noted see Section 3.3 that the equilib-
rium between active and de-activated enzyme does
not depend on temperature. Since the residual activity
in the experiments depicted in Fig. 6 was only a
small fraction of the full catalytic capacity of the
enzyme an accuracy of that notion is not high. The
temperature independence of the equilibrium was
much more prominent in the experiments shown in
Fig. 7 where the final level of the activity reached
about 50% of the original value. It is evident that the
 .Fig. 6. Time-course of de-activation. Active SMP 2 mgrml
were incubated at 308C and the initial rates of uncoupled NADH
w x  .oxidase in the presence of 15 mM MgCl 32 ‘ and2
rotenone-sensitive succinate-ferricyanide reductase reverse elec-
.tron transfer in the presence of 10 mM succinate and 100 mM
 .ferricyanide v were assayed. Insert: magnified ordinate at the
time intervals indicated. The slight difference in the residual
 .  .activities for ‘ and v is due to incomplete inhibition of
inactive“active transition during assay in the presence of Mg2q
w x32 , thus a precision of the kinetics and equilibria is much better
for the reverse electron transfer assay. 100% correspond to the
 .specific activities of 1.1 mmolrmin per mg ‘ and 0.5
 .mmolrmin per mg v .
Fig. 7. Effect of rotenone on activerinactive transition. Active
 .  .SMP 2 mgrml were incubated at 308C or 398C ’ and the
rates of rotenone-sensitive succinate-ferricyanide reductase re-
.verse electron transfer were measured in the standard reaction
 .mixture containing BSA 1 mgrml after 10 min incubation of
 .  .SMP 20 mgrml to remove rotenone. Curve 1 ‘ , no rotenone
 .was added; curve 2 v , 2 mM rotenone was added; curve 3
 .0 , 2 mM rotenone was added after de-activation in the
absence of rotenone has completed. 100% correspond to the
specific activity of 0.5 mmolrmin per mg.
protecting and reactivating effect of rotenone in the
thermally induced de-activation is due to the signifi-
cant difference in the affinity of the inhibitor to the
different enzyme forms which are present as the
slowly equilibrating mixture.
4. Discussion
Large number of the substances are known to
inhibit NADH-ubiquinone reductase at the quinone
w xjunction site 25,27,28,39–41 and references cited
.therein . Most, if not all of them act at the site which
is the same or close to that where inhibitory rotenone
binds. In recent years there have been significant
w xadvances in finding rotenone-like inhibitors 39–41
and it is commonly used practice to relate the effects
of new inhibitors to those of rotenone. In light of the
data reported here this approach may lead to erro-
neous conclusions and clear description of the in-
hibitory effect of rotenone in the simple text-book
terms seemed desirable.
Since the original studies of Burgos and Redfearn
w x13 it is generally accepted that an ‘unusual’ feature
of the inhibition by rotenone is the lag-period which
occurs before the full effect in the inhibition becomes
established. The kinetic and equilibrium constants we
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have determined are characteristic for the tight-bind-
w xing inhibitors 42 . We have previously experienced
this type of inhibition in our studies of succinate
 .dehydrogenase EC 1.3.99.1 -oxaloacetate interaction
w x43 and several features of the tight binding kinetics
worth to emphasize. When the affinity of an enzyme
to an inhibitor is very high K has the same order ofi
magnitude as the concentration of an enzyme under
.the conditions used for assay, or less both the associ-
ation and dissociation reactions becomes very slow.
The former is slow because the apparent first-order
 w x.rate constant k P I is small when very low con-on
centration of an inhibitor is required for significant
inhibition. The latter is slow because of intrinsic
nature of tight binding. The second-order rate con-
 7stant for inhibition of ‘pulsed’ Complex I 5.5P10
y1 y1 .M min at 258C is within the range for rapid
 .enzyme-substrate ligand interaction with the upper
w xlimit set by the diffusion 44 . Thus bimolecular
interaction of rotenone and Complex I is as rapid as
that expected for the substrates NADH and
.ubiquinone . It follows that the equilibration between
 .Complex I, rotenone, substrate quinone andror an-
other inhibitor will be never reached within the time
scale of the enzymatic assay and the type of inhibi-
tion would always appear as non-competitive inde-
pendently of whether real competition between
rotenone and a substance under investigation for the
common binding site exists. Indeed, no competition
between quinone acceptor and rotenone was found
when assumption on equilibrium was implicitly ap-
w xplied for non-equilibrium conditions 27,28 . On the
other hand, an apparent competition would only be-
come evident when the inhibition rate is measured as
a function of the competing substrate concentration.
Two forms of the membrane-bound or isolated
Complex I were identified in our previous studies on
the pre-steady-state kinetics of the rotenone-sensitive
w xreactions catalyzed by the enzyme 34 and the ther-
mally induced de-activation was originally analyzed
w xin terms of irreversible kinetics 31,33 . More close
examination reported here showed that an equilib-
rium between those forms is established. It is not
surprising that the equilibrium was overlooked be-
cause the residual rotenone-sensitive activity of
NADH oxidase is only a small fraction of the original
 .activity Figs. 6 and 7 . The equilibrium between two
forms may have two important consequences. First
one is concerned with the physiologically significant
control mechanism of the reducing equivalents entry
point to the respiratory chain. Although the equilib-
rium is temperature independent, it is expected that
the rate of equilibration at physiological temperature
is high and the steady-state electron flow would
controlled not only by the NADHrNADq and
QrQH ratios but also by the activerinactive en-2
zyme ratio. The second point worth mentioning is
that a substantial fraction of free energy available
from the reaction: NADHqQ“NADqqQH is2
coupled with the enzyme inactive“active transition
in the ‘activating’ turnover, thus it appears that free
energy of the enzyme-catalyzed reaction is partially
used to maintain the catalytically competent enzyme
conformation. In other words NADH-ubiquinone re-
ductase is an interesting example of the energy-trans-
ducting machinery which consumes an energy thus
being not a ‘perfect’ catalyst. Since a dramatic differ-
ence in the affinity of the active and de-activated
forms to rotenone is evident it seems likely that
rotenone clamps the ‘non-equilibrium’ pulsed state,
and an extremely tight binding of rotenone suggests
that the enzyme-inhibitor complex is likely falls into
w xa transition-state analogue category 45 .
qWe were unable to demonstrate any Dm -depend-H
ency of rotenone affinity to NADH oxidase inhibitory
 .site Fig. 2B . However, much lower than NADH
oxidase sensitivity of the reverse electron transfer to
the inhibitor was confirmed. Kotlyar and Gutman
have offered an explanation for different sensitivity
of the direct and reverse reactions which was based
on two assumptions: first, that the affinity of rotenone
qis Dm -dependent; second, that two populations ofH
the submitochondrial particles exist and only ‘cou-
pled’ particles catalyze the reverse reaction whereas
NADH oxidase is catalyzed by ‘uncoupled’ particles
w x38 . Besides the lack of experimental evidence for
functional heterogeneity of our tightly coupled sub-
mitochondrial particles preparations, the second as-
sumption is hard to accept on the quantitative basis.
The preparations routinely used in our laboratory
show an average respiratory control ratio of 8 with
NADH as the substrate. The specific activity in the
reverse electron transfer is about one-fourth of that in
w xthe uncoupled NADH oxidase assay 31 . If only a
 . .small fraction of the particles 1:8 P100s;12%
catalyzes the reverse electron transfer the enzyme
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turnover number in the reverse electron transfer reac-
tion should be much higher than that in NADH
oxidase. Such a conclusion is hard to accept either
kinetically and thermodynamically or physiologically.
Moreover it is hard if not impossible to explain
quantitatively the aerobic succinate-supported reverse
electron transfer with the assumption on a small
qfraction of the particles involved in Dm -dependentH
reactions. To explain different sensitivity of Complex
I to rotenone in the ubiquinone reductase and reverse
electron transfer reactions we propose that different
binding sites for oxidized and reduced ubiquinone
with different affinity to rotenone are operating in
either reactions. In other words the precise mecha-
nisms of the direct and reverse reactions catalyzed by
Complex I are not the same. Such an apparent viola-
tion of the microreversibility principle appears to
hold for other enzymes of the energy-transducing
w xmembrane 46,47 . The experimental data which sup-
port this hypothesis will be published elsewhere.
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